Matthew J D'Onofrio

CIK 1578770 · Chief Executive Officer · last filed 2025-12-17

Matthew J D'Onofrio is a Chief Executive Officer who has filed 25 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for EVOK, was dated Dec 17, 2025. Across all open-market trades the lifetime net is −$134.1K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

25

Lifetime Open-Market Net

-$134.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Evoke Pharma Inc (EVOK) Delisted Chief Executive Officer 0 $11.00 $0 -$134.1K 13 2025-12-17
Evoke Pharma Inc (OMED) Delisted Exec VP, Chief Bus. Officer 238,759 $0 12 2019-02-08

Recent Filings

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-17 Evoke Pharma Inc (EVOK) Delisted Mixed −15,509 $0 EDGAR
2025-03-24 Evoke Pharma Inc (EVOK) Delisted Grant (A) +1,000 $2.8K EDGAR
2025-03-03 Evoke Pharma Inc (EVOK) Delisted Grant (A) +6,849 $25.0K EDGAR
2025-01-29 Evoke Pharma Inc (EVOK) Delisted Grant (A) $0 EDGAR
2024-08-08 Evoke Pharma Inc (EVOK) Delisted Grant (A) $0 EDGAR
2023-02-10 Evoke Pharma Inc (EVOK) Delisted Grant (A) $0 EDGAR
2022-02-04 Evoke Pharma Inc (EVOK) Delisted Grant (A) $0 EDGAR
2021-01-29 Evoke Pharma Inc (EVOK) Delisted Grant (A) $0 EDGAR
2020-12-14 Evoke Pharma Inc (EVOK) Delisted Sell (S) −46,000 -$134.1K EDGAR
2020-12-11 Evoke Pharma Inc (EVOK) Delisted Exer (M) +46,000 $18.4K EDGAR
Showing 110 of 25
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.